LEAP THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events

On April 12, 2023 Leap Therapeutics, Inc. (the "Company") issued a press release entitled "Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients."

The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference; provided, however that information on or connected to our website referenced in the Company's press release is expressly not incorporated by reference into or intended to be filed as a part of this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d)    Exhibits.



 Exhibit
  Number                                 Description
   99.1        Press Release dated April 12, 2023.
   104       Cover Page Interactive Data File. (Embedded within the Inline XBRL
             document.)




                                     - 2 -

© Edgar Online, source Glimpses